New Jersey State Commission on Cancer Research (NJCCR): For more than 30 years, NJCCR has funded promising cancer research in New Jersey. NJCCR promotes significant and original research in New Jersey into causes, prevention, treatment, and palliation of cancer and serves as a resource to providers and consumers of cancer services. ACS CAN will advocate that New Jersey maintain the $4 million in funding for the NJCCR in Fiscal Year 2023-24.
